ArticleJournal of translational medicine2012

Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer.

Yiqing Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.